-
Je něco špatně v tomto záznamu ?
Development of an ultra-high performance liquid chromatography-tandem mass spectrometry method for the determination of anabolic steroids currently available on the black market in the Czech Republic and Slovakia
B. Tircova, Z. Bosakova, P. Kozlik,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
PubMed
30426709
DOI
10.1002/dta.2541
Knihovny.cz E-zdroje
- MeSH
- injekce statistika a číselné údaje MeSH
- kongenery testosteronu analýza ekonomika MeSH
- lidé MeSH
- tablety MeSH
- tandemová hmotnostní spektrometrie metody MeSH
- tobolky MeSH
- vysokoúčinná kapalinová chromatografie metody MeSH
- zločin ekonomika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
- Slovenská republika MeSH
Over the past decade, the use of anabolic androgenic steroids (AAS) by recreational bodybuilders and regular gym members has been increasing exponentially. However, there is a lack of knowledge on AAS products sold in the Czech Republic and Slovakia. The aim of this study was to assess the quantity of active substances in AAS products obtained from AAS users in the Czech Republic and Slovakia. In addition, the study also examines the current trends in counterfeit AAS products used by recreational bodybuilders and regular gym members. For this purpose, the authors developed and validated a universal ultra-high performance liquid chromatography with tandem mass spectrometry method to determine the most popular doping substances in different pharmaceutical formulations (oil-based injectables, tablets, and capsules). This method was successfully utilized for the analysis of 358 AAS products. Our results showed that 58.9% AAS products analyzed contained the declared active substances at the declared concentrations, 15.9% contained no active substance, 16.8% were under-concentrated, 4.5% contained active substances different from those declared on the label, and 3.6% products were over-concentrated. Alarmingly, the results demonstrated that over 40% of the AAS analyzed failed to meet label claims and therefore may pose serious health risks to consumers. This study also highlighted that the availability of AAS should be more rigorously restricted and their quality closely monitored in order to protect AAS users. In conclusion, the authors have developed a precise, accurate, sensitive, selective, and robust method for the routine screening of products containing anabolic androgenic steroids.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034903
- 003
- CZ-PrNML
- 005
- 20210217114607.0
- 007
- ta
- 008
- 191007s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/dta.2541 $2 doi
- 035 __
- $a (PubMed)30426709
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Tircova, Barbora $u Department of Chemistry, Faculty of Natural Science, Matej Bel University in Banska Bystrica, Banska Bystrica, Slovakia.
- 245 10
- $a Development of an ultra-high performance liquid chromatography-tandem mass spectrometry method for the determination of anabolic steroids currently available on the black market in the Czech Republic and Slovakia / $c B. Tircova, Z. Bosakova, P. Kozlik,
- 520 9_
- $a Over the past decade, the use of anabolic androgenic steroids (AAS) by recreational bodybuilders and regular gym members has been increasing exponentially. However, there is a lack of knowledge on AAS products sold in the Czech Republic and Slovakia. The aim of this study was to assess the quantity of active substances in AAS products obtained from AAS users in the Czech Republic and Slovakia. In addition, the study also examines the current trends in counterfeit AAS products used by recreational bodybuilders and regular gym members. For this purpose, the authors developed and validated a universal ultra-high performance liquid chromatography with tandem mass spectrometry method to determine the most popular doping substances in different pharmaceutical formulations (oil-based injectables, tablets, and capsules). This method was successfully utilized for the analysis of 358 AAS products. Our results showed that 58.9% AAS products analyzed contained the declared active substances at the declared concentrations, 15.9% contained no active substance, 16.8% were under-concentrated, 4.5% contained active substances different from those declared on the label, and 3.6% products were over-concentrated. Alarmingly, the results demonstrated that over 40% of the AAS analyzed failed to meet label claims and therefore may pose serious health risks to consumers. This study also highlighted that the availability of AAS should be more rigorously restricted and their quality closely monitored in order to protect AAS users. In conclusion, the authors have developed a precise, accurate, sensitive, selective, and robust method for the routine screening of products containing anabolic androgenic steroids.
- 650 _2
- $a tobolky $7 D002214
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a zločin $x ekonomika $7 D003415
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a injekce $x statistika a číselné údaje $7 D007267
- 650 _2
- $a tablety $7 D013607
- 650 _2
- $a tandemová hmotnostní spektrometrie $x metody $7 D053719
- 650 _2
- $a kongenery testosteronu $x analýza $x ekonomika $7 D045165
- 651 _2
- $a Česká republika $7 D018153
- 651 _2
- $a Slovenská republika $7 D018154
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bosakova, Zuzana $u Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.
- 700 1_
- $a Kozlík, Petr $u Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic. $7 xx0257220
- 773 0_
- $w MED00188061 $t Drug testing and analysis $x 1942-7611 $g Roč. 11, č. 2 (2019), s. 355-360
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30426709 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20210217114522 $b ABA008
- 999 __
- $a ok $b bmc $g 1451563 $s 1073453
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 11 $c 2 $d 355-360 $e 20181126 $i 1942-7611 $m Drug testing and analysis $n Drug Test Anal $x MED00188061
- LZP __
- $a Pubmed-20191007